By: Business Editor
Jordan Daily - Pharmaceutical company Hikma Pharmaceuticals announced plans this week to significantly expand its manufacturing operations in Ohio, investing in facilities in Columbus and Bedford as part of a broader push to strengthen domestic medicine production.
The expansion will increase Hikma's manufacturing capacity and create 350 new jobs across the two cities, the company said. The project forms part of the $1 billion in new U.S. investments that Hikma announced in June 2025.
Ohio Governor Mike DeWine joined Hikma executives, officials from the cities of Columbus and Bedford, and other state and local partners to announce the investment.
“Hikma’s expanded facilities in central and northeast Ohio will strengthen its ability to ensure patients have reliable access to the medicines they need,” DeWine said in a statement. “This significant investment reaffirms Hikma’s commitment to the state, creating high-quality jobs and signaling to the industry that Ohio will continue to be a major player in the future of healthcare.”
Hikma said the Ohio expansion reflects its long-term commitment to growing its U.S. operations and supporting the supply of essential medicines.
